A 22 year-old woman with a familial history of multiple breast cancers had presented in 2005 with an IDC of the right breast (cT2N1, ER+, PR+, HER2+) that had been treated with neo-adjuvant chemotherapy and traztuzumab. This evidence concerns the gene ERBB2 and breast carcinoma.